Abeona Therapeutics Inc. (ABEO)
NASDAQ: ABEO · Real-Time Price · USD
6.80
+0.05 (0.74%)
At close: Jul 30, 2025, 4:00 PM
6.81
+0.01 (0.15%)
Pre-market: Jul 31, 2025, 7:33 AM EDT
Abeona Therapeutics Employees
Abeona Therapeutics had 136 employees as of December 31, 2024. The number of employees increased by 52 or 61.90% compared to the previous year.
Employees
136
Change (1Y)
52
Growth (1Y)
61.90%
Revenue / Employee
n/a
Profits / Employee
-$324,890
Market Cap
347.87M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 136 | 52 | 61.90% |
| Dec 31, 2023 | 84 | 27 | 47.37% |
| Dec 31, 2022 | 57 | -33 | -36.67% |
| Dec 31, 2021 | 90 | 14 | 18.42% |
| Dec 31, 2020 | 76 | -12 | -13.64% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ABEO News
- 1 day ago - AscellaHealth HUB Partnership with Abeona Therapeutics® Supports Launch Success of Novel Cell-Based Gene Therapy and Access to Treatment for Rare Disease Patients - GlobeNewsWire
- 16 days ago - ZEVASKYN™ Gene Therapy Now Available at New Qualified Treatment Center in San Francisco Bay Area - GlobeNewsWire
- 17 days ago - Bio-Techne's Simple Western™ Technology Utilized in Recent FDA Approval of ZEVASKYN™ Cell-Based Gene Therapy - PRNewsWire
- 4 weeks ago - Abeona Therapeutics® Closes Sale of Rare Pediatric Disease Priority Review Voucher for $155 Million - GlobeNewsWire
- 4 weeks ago - Abeona Therapeutics® Announces Option Exercise by Beacon Therapeutics for Novel AAV204 Capsid for Ophthalmology Gene Therapy - GlobeNewsWire
- 4 weeks ago - Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 weeks ago - Abeona Therapeutics® added to Membership of U.S. Small-cap Russell 2000® Index and Broad-market Russell 3000® Index - GlobeNewsWire
- 5 weeks ago - Abeona Therapeutics® Announces Publication in The Lancet of Phase 3 VIITAL™ Study Data in Recessive Dystrophic Epidermolysis Bullosa - GlobeNewsWire